SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 54 filers reported holding SAVARA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $124,377 | -29.8% | 63,783 | -44.2% | 0.00% | -100.0% |
Q4 2022 | $177,122 | -6.3% | 114,272 | -6.3% | 0.00% | 0.0% |
Q3 2022 | $189,000 | -5.0% | 121,896 | -7.1% | 0.00% | 0.0% |
Q2 2022 | $199,000 | -45.9% | 131,194 | -53.3% | 0.00% | 0.0% |
Q1 2022 | $368,000 | -50.9% | 280,785 | -53.5% | 0.00% | -50.0% |
Q4 2021 | $749,000 | +8.2% | 603,768 | +20.3% | 0.00% | 0.0% |
Q3 2021 | $692,000 | -6.0% | 501,757 | +15.9% | 0.00% | 0.0% |
Q2 2021 | $736,000 | +2528.6% | 432,923 | +1594.2% | 0.00% | – |
Q3 2020 | $28,000 | -91.6% | 25,553 | -80.9% | 0.00% | -100.0% |
Q2 2020 | $333,000 | +12.5% | 133,933 | +20.0% | 0.00% | +100.0% |
Q3 2019 | $296,000 | – | 111,587 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
Woodline Partners LP | 374,904 | $431,000 | 0.01% |
Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |